CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer

CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer

The development of chemoresistance reduces the efficacy of anti‐cancer drugs. Cervical cancer is still one of the most common cancer types in developing countries. The oncogenic protein high mobility group AT‐hook 2 (HMGA2) is involved in the development and progression of tumors, although its role...

Full description

Bibliographic Details
Main Authors: Zhan Shi, Ding Wu, Hao Xu, Ju Yang, Xiaoqing Sun
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:FEBS Open Bio
Subjects:
cervical cancer
chemoresistance
cisplatin
CSNK2A1
HMGA2
Online Access:https://doi.org/10.1002/2211-5463.13228

Similar Items

Similar Items